Article | October 1, 2024

A Robust Extractables Data Package Helps Drive Patient Safety

By Will Parker, Manager, Extractables & Leachables

GettyImages-1181392775 lab, research

The scrutiny of extractables and leachables (E&L) from pharmaceutical packaging and delivery systems has intensified significantly since its inception in the mid-1990s. Regulatory agencies have become more knowledgeable, leading to heightened expectations for the industry. Guidelines such as USP and, along with injectable drug recommendations from the Product Quality Research Institute (PQRI), exemplify this evolving landscape. As drug formulations grow in complexity, a thorough understanding of extractables is essential to mitigate potential risks arising from interactions between packaging and the drug product.

Access the full article to understand how to best manage these risks.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Med Device Online? Subscribe today.

Subscribe to Med Device Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Med Device Online

West Pharmaceutical Services, Inc.